Unless otherwise indicated, faculty members, moderators, activity planners & CME Committee members have disclosed no relevant financial relationships. ACOI staff members have disclosed no relevant financial relationships.

The following faculty have disclosed financial relationships, and all relevant financial relationships were mitigated:

2026 Internal Medicine Comprehensive Update

• Chad Link, DO, FACC, FACOI: Kiniksa Pharmaceuticals (Consulting Fee)
• Keith Reich, DO, MACOI: Kyowa Kirin (Consulting Fee)
• Jack Snitzer, DO, FACOI: Dexcom (Consulting Fee)
• David Strobl, DO: Amgen (Consulting Fee, Speaker Bureau)

2026 Clinical Challenges in Hospital Medicine

• Jeffrey Freeman, DO, FACOI: Mankind (Consulting Fee), Novo Nordisk (Consulting Fee)
• Chad Link, DO, FACC, FACOI: Kiniksa Pharmaceuticals (Consulting Fee)
• Robby Wu, DO: Cytokinetics (Consulting/Speaker Bureau), Bristol Myers Squibb (Consulting/Speaker Bureau)